Emami Armaghan, Tepper Jeff, Short Brian, Yaksh Tony L, Bendele Alison M, Ramani Thulasi, Cisternas Alvaro F, Chang Jay H, Mellon R Daniel
1 US Food and Drug Administration, Silver Spring, MD, USA.
2 Tepper Nonclinical Consulting, San Carlos, CA, USA.
Int J Toxicol. 2018 Jan/Feb;37(1):4-27. doi: 10.1177/1091581817741840. Epub 2017 Dec 21.
As the need for nasal, ocular, spinal, and articular therapeutic compounds increases, toxicology assessments of drugs administered via these routes play an important role in human safety. This symposium outlined the local and systemic evaluation to support safety during the development of these drugs in nonclinical models with some case studies. Discussions included selection of appropriate species for the intended route; conducting nonclinical studies that closely mimic the intended use with adequate duration; functional assessment, if deemed necessary; evaluation of local tissues with special histological staining procedure; and evaluations of safety margins based on local and systemic toxicity.
随着对鼻腔、眼部、脊柱和关节治疗化合物需求的增加,通过这些途径给药的药物毒理学评估在人类安全方面发挥着重要作用。本次研讨会概述了在非临床模型中开发这些药物时支持安全性的局部和全身评估,并列举了一些案例研究。讨论内容包括为预期给药途径选择合适的物种;进行能紧密模拟预期用途且持续时间足够的非临床研究;如有必要进行功能评估;采用特殊组织学染色程序评估局部组织;以及基于局部和全身毒性评估安全边际。